<p><strong>Children and Adolescents</strong>: Limited safety and efficacy data available on women under 18 years old.<br />
<br />
<strong>Hepatic Impairment</strong>: No studies have been conducted to evaluate the effect of hepatic disease on the disposition of Ulipristal Acetate.<br />
<br />
<strong>Renal Impairment</strong>: No studies have been conducted to evaluate the effect of renal disease on the disposition of Ulipristal Acetate.</p>